Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 2
1(16.7%)
6Total
N/A(5)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02069743Not ApplicableCompleted

Pain Management in Cancer Patients Using a Mobile Application

Role: collaborator

NCT01569243Phase 2Completed

Text to Move (TTM)Study

Role: collaborator

NCT02375776Not ApplicableCompleted

Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health Intervention

Role: collaborator

NCT02238951Not ApplicableCompleted

Cancer Care Coordination for Chemotherapy Patients

Role: collaborator

NCT02460822Not ApplicableCompleted

Developing an mHealth Application to Improve Cancer Chemotherapy Symptom Management

Role: collaborator

NCT01749176Not ApplicableCompleted

Dulce Digital-Project Dulce 2.0 Texting Study

Role: collaborator

All 6 trials loaded